36.83 USD
↗ 0.70 (1.94%)AT CLOSE (03:59 PM EDT)
Harmony Biosciences Holdings, Inc. Common Stock
HRMYNASDAQ • USD
36.90
↗ 0.07 (0.19%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
36.90
↗ 0.07 (0.19%)
Market: CLOSED
Harmony Biosciences Holdings, Inc. Common Stock (HRMY) trades at $36.83 per share. The stock presents a mixed profile: our models indicate a Buy for underlying fundamentals, while technical indicators flash a Sell. This is driven by a robust Altman Z-Score and a bullish Golden Cross on the moving averages. Valuation metrics suggest HRMY is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 26, 2026.
Open?$36.28
High?$37.19
Low?$36.13
Prev. Close?$36.13
Volume?852.7K
Avg. Volume?1.1M
VWAP?$36.76
Rel. Volume?0.77x
Bid / Ask
Bid?$30.14 × 100
Ask?$43.47 × 100
Spread?$13.33
Midpoint?$36.81
Valuation & Ratios
Market Cap?2.1B
Shares Out?58.2M
Float?45.7M
Float %?78.5%
P/E Ratio?11.61
P/B Ratio?2.11
EPS?$3.11
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Themes
Employees
293
Market Cap
2.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-08-19
Address
630 W GERMANTOWN PIKE
PLYMOUTH MEETING, PA 19462
Phone: (484) 539-9800
PLYMOUTH MEETING, PA 19462
Phone: (484) 539-9800
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?99
Momentum?75
Short Sent.?34
Piotroski F-Score?5/9Mixed
Altman Z-Score?5.41Safe
Confidence?61%Moderate
Short InterestHigh
Short % of Float?11.84%High
Short Interest?5.4M
Days to Cover?6.2
Free Float45.7M
Avg Daily Volume876.1K
Settlement Date2026-10-15
Financial Health
Current Ratio?3.48Strong
Quick Ratio?3.45Strong
Cash Ratio?2.35Strong
Debt/Equity?0.15Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?11.6CHEAP▾
Peers100
S&P92
P/B?2.11CHEAP▾
Peers100
S&P72
P/S?2.19CHEAP▾
Peers100
S&P62
P/FCF?5.9CHEAP▾
Peers100
S&P97
EV/EBITDA?7.0CHEAP▾
Peers100
S&P94
EV/Sales?1.78CHEAP▾
Peers100
S&P79
Returns & Efficiency
ROE?18.1%STRONG▾
Peers50
S&P62
ROA?13.2%STRONG▾
Peers50
S&P83
Cash Flow & Enterprise
FCF?$354.9M
Enterprise Value?$1.7B
Fundamentals ratios updated end of day